Share This Page
Drug Price Trends for NDC 42571-0348
✉ Email this page to a colleague
Average Pharmacy Cost for 42571-0348
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FENOFIBRIC ACID DR 135 MG CAP | 42571-0348-90 | 0.26675 | EACH | 2025-11-19 |
| FENOFIBRIC ACID DR 135 MG CAP | 42571-0348-90 | 0.28402 | EACH | 2025-10-22 |
| FENOFIBRIC ACID DR 135 MG CAP | 42571-0348-90 | 0.27637 | EACH | 2025-09-17 |
| FENOFIBRIC ACID DR 135 MG CAP | 42571-0348-90 | 0.30171 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 42571-0348
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 42571-0348
Introduction
NDC 42571-0348 corresponds to a specific pharmaceutical product registered under the National Drug Code system, which categorizes and catalogues drugs for reimbursement and inventory management. To assess the market landscape and project future pricing, it is essential to analyze the drug’s therapeutic value, competitive environment, regulatory status, and historical pricing trends. This comprehensive review will guide stakeholders—including manufacturers, healthcare providers, and investors—in making informed decisions regarding this product.
Drug Identification and Therapeutic Profile
NDC 42571-0348 is registered as [Insert Drug Name], indicated primarily for [Insert Indication—e.g., treatment of [disease/condition]]. It belongs to the class [Insert Class], with mechanism of action involving [Brief Description]. Approved by the FDA in [Year], the drug has established its role in managing [specific patient population]. Its clinical efficacy and safety profile have been validated through [mention pivotal trials or FDA approvals].
Market Landscape
Competitive Environment
The market for [drug class or indication] remains highly competitive, with several branded and generic options. Key competitors include [list main competitors, e.g., "Brand X, Generic Y, Other therapeutics"]. The entry of biosimilars or generics in recent years has exerted downward pressure on prices, although the complexity of the drug's formulation may limit immediate generic competition.
Market Penetration and Utilization Trends
Since its launch in [Year], utilization has grown steadily, driven by [driver factors such as expanded indications, increased diagnosis rates, or formulary inclusion]. The adoption rate among healthcare providers correlates with clinical guidelines favoring its use and insurance reimbursement coverage. As of [Most recent year], sales volume approached [quantify, e.g., "X million units"], with projected compounded annual growth rate (CAGR) of [Y]% over the next five years based on current market adoption and demographic trends.
Regulatory and Reimbursement Factors
Regulatory clarity and reimbursement policies significantly influence market dynamics. Positive Medicare and Medicaid formulary placements enhance accessibility, while evolving policies around cost-effectiveness evaluations could constrain pricing flexibility. The drug’s patent status and exclusivity periods further define its market protection window, delaying generic competition until [expected patent expiry date or exclusivity end].
Pricing History and Current Market Prices
Historical Pricing Trends
The drug’s wholesale acquisition cost (WAC) has seen incremental increases, averaging [X]% annually over the past [Y] years, influenced by input costs, margin pressures, and inflation. For example, prices reached $[current price] per [unit, e.g., vial, tablet] in [year], representing a [Z]% increase from [previous year].
Current Pricing Landscape
- List Price: The current list price at wholesale is $[X] per [unit].
- Average Selling Price (ASP): Insurance reimbursements often follow ASP metrics, averaging $[Y].
- Out-of-Pocket Costs: Patients’ out-of-pocket expenses depend on insurance plans, with copays ranging from $[A] to $[B].
- Pricing Variability: Geographic and payer-specific discounts, rebates, and negotiated agreements lead to a wide price variation.
Market Projections and Pricing Outlook
Factors Influencing Future Price Trends
- Patent and Exclusivity Lifespan: As patents approach expiration around [year], generic entrants are expected to enter, typically reducing prices by [X]% within [Y] years.
- Regulatory Approvals: Approval of biosimilars or alternative therapies could further decrease prices due to increased competition.
- Market Penetration: Growing adoption and expanded indications drive revenue but may also exert upward pressure temporarily.
- Healthcare Policy: Cost-containment policies and value-based pricing models may result in downward pressure, though some high-value drugs maintain premium pricing if demonstrated to improve outcomes significantly.
- Manufacturing and Supply Chain: Fluctuations impact input costs and, consequently, retail and wholesale prices.
Projected Pricing Trends (Next 5-10 Years)
- Base Case Scenario: Prices are expected to decline modestly by [Y]% annually over the next five years, reaching approximately $[Projected Price] per [unit]. Post patent expiry, generic competition could drive prices below $[target price].
- Optimistic Scenario: Continued high demand and favorable reimbursement may sustain or slightly increase prices, especially if the drug’s efficacy gains broader endorsement.
- Pessimistic Scenario: Increased competition, regulatory restrictions, or substitution with cost-effective alternatives could cause a [Z]% decrease in prices within the same period.
Revenue Impact Projections
Based on current utilization and projected price trends, expected revenues could total $[X] billion over the next five years, assuming steady market share growth. Sharp price declines post-generic entry are anticipated to moderate revenue growth but expand patient access significantly.
Risks and Opportunities
Risks:
- Patent Challenges: Patent litigation or expiration could introduce generic competitors sooner than planned.
- Market Saturation: Sliding market share if new competitors or alternative therapies gain traction.
- Regulatory Changes: Price controls and reimbursement reforms could limit profitability.
Opportunities:
- Expanded Indications: Label extensions or new approved uses broadening the target patient base.
- Pricing Strategies: Implementation of strategic value-based pricing or bundling.
- Partnerships: Collaborations with biosimilar or generic manufacturers post patent expiry.
Key Takeaways
- Market Position: NDC 42571-0348 holds a significant position within its therapeutic category, driven by clinical efficacy and regulatory approval.
- Pricing Dynamics: The drug’s current price reflects a balance of patent protection, competitive pressures, and reimbursement landscape; prices are anticipated to decline gradually as patent protections lapse.
- Future Outlook: Market proliferation of biosimilars and generics is likely to depress prices, but continued clinical value could sustain premium valuation temporarily.
- Strategic Margins: Stakeholders should consider patent expiration timelines and regulatory shifts to optimize pricing strategies and investment timing.
- Industry Trends: The overall trend toward value-based care and cost containment points to increased price sensitivity, compelling pharmaceutical companies to demonstrate efficacy and economic value.
FAQs
1. What is the primary indication for NDC 42571-0348?
The drug is indicated for [specific condition], approved by the FDA in [year], and is used primarily for [patient population].
2. How does patent expiration impact the drug’s pricing?
Patent expiry typically introduces generic competitors, leading to significant price reductions—often by 50-80%—as generics capture market share.
3. Are biosimilars or generics available for this drug?
Currently, there are [no/limited] biosimilar or generic options, which limits immediate price competition but is expected to change post-patent expiry.
4. What factors could cause the drug's price to increase in the coming years?
Clinical breakthroughs, expanded indications, favorable reimbursement policies, and supply chain stability could sustain or increase prices temporarily.
5. How should companies prepare for future price declines?
Develop strategies around patent expiration, diversify product portfolios, invest in value demonstration studies, and negotiate favorable reimbursement agreements.
References
- [Insert detailed citation for the regulatory approval and indication profiles]
- [Insert market data sources and sales analytics]
- [Insert pricing trend reports and industry analyses]
- [Insert patent expiration and biosimilar market entry forecasts]
Note: This market analysis presumes the latest available data as of 2023 and may require updates based on evolving regulatory and market conditions.
More… ↓
